These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1804008)

  • 1. Crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin alone and in combination in healthy elderly volunteers.
    Weinstein MP; Deeter RG; Swanson KA; Gross JS
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2352-8. PubMed ID: 1804008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Killing rate and serum bactericidal activity of oxacillin, rifampin and ciprofloxacin against Staphylococcus aureus.
    Moretti MV; Fiorio M; Pasticci MB; Moretti A; Baldelli F; Pauluzzi S
    Microbiologica; 1989 Oct; 12(4):297-306. PubMed ID: 2586332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and serum bactericidal activities of quinolones in combination with clindamycin, metronidazole, and ornidazole.
    Boeckh M; Lode H; Deppermann KM; Grineisen S; Shokry F; Held R; Wernicke K; Koeppe P; Wagner J; Krasemann C
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2407-14. PubMed ID: 2088195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin and ofloxacin.
    Echols R; Weinstein MP; O'Keeffe B; Shah A; Heller AH
    J Antimicrob Chemother; 1994 Jan; 33(1):111-8. PubMed ID: 8157551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal activity and killing rate of serum in volunteers receiving ciprofloxacin alone or in combination with vancomycin.
    Van der Auwera P; Klastersky J
    Antimicrob Agents Chemother; 1986 Dec; 30(6):892-5. PubMed ID: 3813515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crossover assessment of serum bactericidal activity and pharmacokinetics of five broad-spectrum cephalosporins in the elderly.
    Deeter RG; Weinstein MP; Swanson KA; Gross JS; Bailey LC
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1007-13. PubMed ID: 2393258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibiotic resistance of Gram-positive cocci isolated in 2008].
    Dorobăţ OM; Bădicuţ I; Tălăpan D; Tenea C; Rafila A
    Bacteriol Virusol Parazitol Epidemiol; 2010; 55(2):83-92. PubMed ID: 21553473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of ciprofloxacin and rifampin alone and in combination against growing and nongrowing strains of methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
    Bahl D; Miller DA; Leviton I; Gialanella P; Wolin MJ; Liu W; Perkins R; Miller MH
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1293-7. PubMed ID: 9174186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antistaphylococcal activity of rifampin with other antibiotics.
    Zinner SH; Lagast H; Klastersky J
    J Infect Dis; 1981 Oct; 144(4):365-71. PubMed ID: 6270215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations in plasma, urinary excretion, and bactericidal activity of linezolid (600 milligrams) versus those of ciprofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Wydra S; Onda H; Kinzig-Schippers M; Sörgel F; Naber KG
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3789-94. PubMed ID: 14638484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose.
    Boy D; Well M; Kinzig-Schippers M; Sörgel F; Ankel-Fuchs D; Naber KG
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S6-16. PubMed ID: 15037323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa.
    Klepser ME; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2503-10. PubMed ID: 8585734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus.
    Hackbarth CJ; Chambers HF; Sande MA
    Antimicrob Agents Chemother; 1986 Apr; 29(4):611-3. PubMed ID: 3707110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
    Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J
    Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination effects of ciprofloxacin, clindamycin, and metronidazole intravenously in volunteers.
    Deppermann KM; Boeckh M; Grineisen S; Shokry F; Borner K; Koeppe P; Krasemann C; Wagner J; Lode H
    Am J Med; 1989 Nov; 87(5A):46S-48S. PubMed ID: 2589383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum bactericidal activity after administration of four cephalosporins in healthy volunteers.
    Lemmen S; Kropec A; Engels I; Busse A; Daschner FD
    Eur J Clin Microbiol Infect Dis; 1993 Nov; 12(11):856-60. PubMed ID: 8112358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium.
    Whitman MS; Pitsakis PG; Zausner A; Livornese LL; Osborne AJ; Johnson CC; Levison ME
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2069-73. PubMed ID: 8257125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of clindamycin in combination with oxacillin, rifampin, or vancomycin against Staphylococcus aureus.
    Ho JL; Klempner MS
    Diagn Microbiol Infect Dis; 1986 Feb; 4(2):133-8. PubMed ID: 3956136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bactericidal activity and killing rate of serum in volunteers receiving teicoplanin alone or in combination with oral or intravenous rifampin.
    Van der Auwera P; Klastersky J
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1002-5. PubMed ID: 2959197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of clindamycin in addition to vancomycin for the treatment of oxacillin-resistant Staphylococcus aureus septicemia persisting under vancomycin therapy.
    Venditti M; Baiocchi P; Santini C; Galetta P; Tarasi A; Brandimarte C; D'Argenio P; Campagnano P
    Int J Antimicrob Agents; 1995 Apr; 5(2):123-8. PubMed ID: 18611659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.